175 related articles for article (PubMed ID: 9744700)
1. Octreotide in the treatment of intestinal lymphangiectasia.
Ballinger AB; Farthing MJ
Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):699-702. PubMed ID: 9744700
[TBL] [Abstract][Full Text] [Related]
2. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.
Filik L; Oguz P; Koksal A; Koklu S; Sahin B
Dig Liver Dis; 2004 Oct; 36(10):687-90. PubMed ID: 15506669
[TBL] [Abstract][Full Text] [Related]
3. Yellow nail syndrome: treatment with octreotide.
Hillerdal G
Clin Respir J; 2007 Dec; 1(2):120-1. PubMed ID: 20298292
[TBL] [Abstract][Full Text] [Related]
4. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment?
Sari S; Baris Z; Dalgic B
J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058
[TBL] [Abstract][Full Text] [Related]
5. Octreotide management of intestinal lymphangiectasia in a teenage heart transplant patient.
Altit G; Patel H; Morinville VD
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):824-7. PubMed ID: 21768882
[No Abstract] [Full Text] [Related]
6. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.
MacLean JE; Cohen E; Weinstein M
Pediatrics; 2002 Jun; 109(6):1177-80. PubMed ID: 12042562
[TBL] [Abstract][Full Text] [Related]
7. How to treat an extensive form of primary intestinal lymphangiectasia?
Troskot R; Jurčić D; Bilić A; Gomerčić Palčić M; Težak S; Brajković I
World J Gastroenterol; 2015 Jun; 21(23):7320-5. PubMed ID: 26109821
[TBL] [Abstract][Full Text] [Related]
8. Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.
Makhija S; von der Weid PY; Meddings J; Urbanski SJ; Beck PL
Can J Gastroenterol; 2004 Nov; 18(11):681-5. PubMed ID: 15565209
[TBL] [Abstract][Full Text] [Related]
9. A case of the yellow nail syndrome associated with massive chylous ascites, pleural and pericardial effusions.
Malek NP; Ocran K; Tietge UJ; Maschek H; Gratz KF; Trautwein C; Wagner S; Manns MP
Z Gastroenterol; 1996 Nov; 34(11):763-6. PubMed ID: 8956479
[TBL] [Abstract][Full Text] [Related]
10. [Yellow nail syndrome associated with intestinal lymphangiectasia].
Desramé J; Béchade D; Patte JH; Jean R; Karsenti D; Coutant G; Algayres JP; Daly JP
Gastroenterol Clin Biol; 2000; 24(8-9):837-40. PubMed ID: 11011259
[TBL] [Abstract][Full Text] [Related]
11. Primary intestinal lymphangiectasia successfully treated with octreotide.
Kuroiwa G; Takayama T; Sato Y; Takahashi Y; Fujita T; Nobuoka A; Kukitsu T; Kato J; Sakamaki S; Niitsu Y
J Gastroenterol; 2001 Feb; 36(2):129-32. PubMed ID: 11227670
[TBL] [Abstract][Full Text] [Related]
12. [Primary intestinal lymphangiectasia: effectiveness of treatment with slow-release octreotide].
Balboa A; Perelló A; Mearin F
Med Clin (Barc); 2004 Sep; 123(8):319. PubMed ID: 15373983
[No Abstract] [Full Text] [Related]
13. Spontaneous neonatal chylothorax treated with octreotide.
Siu SL; Lam DS
J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
[TBL] [Abstract][Full Text] [Related]
14. What are the objectives of treatment for intestinal lymphangiectasia?
Takahashi H; Imai K
J Gastroenterol; 2001 Feb; 36(2):137-8. PubMed ID: 11227672
[No Abstract] [Full Text] [Related]
15. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report.
Lee HL; Han DS; Kim JB; Jeon YC; Sohn JH; Hahm JS
J Korean Med Sci; 2004 Jun; 19(3):466-9. PubMed ID: 15201518
[TBL] [Abstract][Full Text] [Related]
16. Octreotide in the treatment of congenital chylothorax.
Rasiah SV; Oei J; Lui K
J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
[TBL] [Abstract][Full Text] [Related]
17. Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.
Al Sinani S; Rawahi YA; Abdoon H
World J Gastroenterol; 2012 Nov; 18(43):6333-7. PubMed ID: 23180957
[TBL] [Abstract][Full Text] [Related]
18. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients.
Nikou GC; Toumpanakis C; Katsiari C; Charalambopoulos D; Sfikakis PP
J Clin Rheumatol; 2007 Jun; 13(3):119-23. PubMed ID: 17551375
[TBL] [Abstract][Full Text] [Related]
19. Successful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphy.
Connor FL; Angelides S; Gibson M; Larden DW; Roman MR; Jones O; Currie BG; Day AS; Bohane TD
Pediatrics; 2003 Sep; 112(3 Pt 1):e242-7. PubMed ID: 12949320
[TBL] [Abstract][Full Text] [Related]
20. Can octreotide be the first line treatment for chylothorax?
Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
